Sang K. Lim, Ph.D. - Publications
Affiliations: | University of Wisconsin, Madison, Madison, WI |
Area:
TGFYear | Citation | Score | |||
---|---|---|---|---|---|
2009 | Ju J, Rajski SR, Lim SK, Seo JW, Peters NR, Hoffmann FM, Shen B. Lactimidomycin, iso-migrastatin and related glutarimide-containing 12-membered macrolides are extremely potent inhibitors of cell migration. Journal of the American Chemical Society. 131: 1370-1. PMID 19132897 DOI: 10.1021/Ja808462P | 0.321 | |||
2008 | Ju J, Rajski SR, Lim SK, Seo JW, Peters NR, Hoffmann FM, Shen B. Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency. Bioorganic & Medicinal Chemistry Letters. 18: 5951-4. PMID 18684620 DOI: 10.1016/J.Bmcl.2008.07.072 | 0.315 | |||
2006 | Lim SK, Hoffmann FM. Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-beta signaling. Proceedings of the National Academy of Sciences of the United States of America. 103: 18580-5. PMID 17132729 DOI: 10.1073/pnas.0604773103 | 0.566 | |||
2005 | Cui Q, Lim SK, Zhao B, Hoffmann FM. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP. Oncogene. 24: 3864-74. PMID 15750622 DOI: 10.1038/Sj.Onc.1208556 | 0.328 | |||
Show low-probability matches. |